Mother’s role in Alzheimer’s: New study highlights genetic impact

Recent findings from a comprehensive study examining 4,413 cognitively unimpaired older adults reveal a startling statistic: individuals with a maternal history of memory impairment exhibit significantly higher levels of neocortical β-amyloid compared to those with just a paternal history or no familial link to the disease [1]. 

This correlation holds irrespective of the age at which symptoms first appeared in the mother, marking a significant breakthrough in understanding Alzheimer’s heredity dynamics.

Alzheimer’s genetic footprint

The study, carried out across various international sites including the US, Australia, Canada, and Japan, specifically investigated the impact of having a mother or father with memory issues on the presence of β-amyloid—a key biomarker for Alzheimer’s disease—in the brain [1]. 

The findings are crucial as they highlight a particular vulnerability tied to maternal transmission of the disease.

What are β-Amyloid’s plaques?

β-Amyloid plaques are sticky build-ups which accumulate in the brain, playing a pivotal role in the onset of Alzheimer’s disease. 

The study’s results showed that having a mother who suffered from memory impairment leads to a greater predisposition to this biomarker, regardless of whether the onset of her symptoms was early or late [1]. 

This contrasted with findings related to paternal history, where only early-onset memory issues were associated with increased β-amyloid levels.

Implications for prevention and early detection

The implications of these findings are significant. They suggest that the maternal lineage might carry a more potent genetic predisposition to Alzheimer’s, which could be pivotal for early screening and preventive measures [1]. 

Understanding that one’s risk could be significantly shaped by their mother’s health history provides a clearer target for early intervention strategies.

Expanding the horizon of genetic research

This study not only sheds light on the specific genetic influences in Alzheimer’s disease but also opens new avenues for research into how genetic factors might influence other neurodegenerative diseases. 

Researchers could potentially identify specific genes that contribute to increased β-amyloid production and accumulation in individuals with a maternal history of memory disorders [1].

The discovery that a mother’s history of memory impairment can significantly influence an individual’s likelihood of developing Alzheimer’s disease underscores the importance of family health history in assessing risk. 

This knowledge equips healthcare providers with better tools for early detection and intervention, potentially altering the course of the disease before symptoms manifest.

The study, reflecting a comprehensive and methodologically sound approach, provides a compelling argument for more personalized approaches to Alzheimer’s prevention and care, highlighting the need for targeted research and tailored interventions based on genetic risk factors.

For more information and to access the full study, visit the study published on JAMA Neurology.


The information included in this article is for informational purposes only. The purpose of this webpage is to promote broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.